Defining DNA Double Strand Breaks and the Role of Homologous Recombination in the Mechanism of Radiosensitization by Gemcitabine.
dc.contributor.author | Im, Michael M. | en_US |
dc.date.accessioned | 2013-06-12T14:17:29Z | |
dc.date.available | NO_RESTRICTION | en_US |
dc.date.available | 2013-06-12T14:17:29Z | |
dc.date.issued | 2013 | en_US |
dc.date.submitted | 2013 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/98033 | |
dc.description.abstract | Gemcitabine (2’,2’-difluoro-2’-deoxycytidine; dFdCyd) is an analog of deoxycytidine used in the treatment of a variety of solid malignancies. When tumor cells in vitro are exposed to dFdCyd prior to ionizing radiation (IR), a synergistic enhancement in cell killing, termed radiosensitization (RS), is observed. While RS with gemcitabine is correlated with depletion of dATP, mediated by gemcitabine diphosphate inhibition of ribonucleotide reductase, and the consequent mismatched nucleotides in DNA, the effect of these events on DNA damage was unknown. This dissertation seeks to elucidate the mechanism underlying this synergy by examining the role of homologous recombination (HR) in DNA double strand break (DSB) formation and resolution. Radiosensitization by other nucleoside analogs is attributed to increased DSBs, or inhibition in their repair. This dissertation shows that the pattern of initial DSB formation and resolution (0-4h post-IR) did not correlate with radiosensitization by gemcitabine (RS-dFdCyd), consistent with earlier reports, however, a second increase was observed at 24 and 48h time points that greatly exceeded the initial DSBs and positively correlated with RS-dFdCyd. I hypothesized that gemcitabine-mediated mismatches in DNA interrupted HR-mediated repair of the late DSBs observed with dFdCyd+IR. The data show that shRNA knockdown of XRCC3, a required HR protein, in human MCF-7 breast cancer cells, completely inhibited RS-dFdCyd. Furthermore, XRCC3 knockdown reduced formation of late DSBs as evidenced by gamma-H2AX foci and phosphorylated ATM evaluation. These data demonstrate for the first time that RS-dFdCyd produces late increases in DSBs, and formation of these DSBs requires HR. I suggest that HR is blocked by the persistent mismatches in DNA produced by gemcitabine. Thus, failed HR-mediated repair of late DSBs is crucial for RS-dFdCyd, suggesting that HR-deficient tumors will be most effectively treated by this approach. | en_US |
dc.language.iso | en_US | en_US |
dc.subject | Radiosensitization by Gemcitabine | en_US |
dc.subject | DFdCyd | en_US |
dc.subject | Homologous Recombination | en_US |
dc.subject | Late Damage | en_US |
dc.title | Defining DNA Double Strand Breaks and the Role of Homologous Recombination in the Mechanism of Radiosensitization by Gemcitabine. | en_US |
dc.type | Thesis | en_US |
dc.description.thesisdegreename | PhD | en_US |
dc.description.thesisdegreediscipline | Pharmacology | en_US |
dc.description.thesisdegreegrantor | University of Michigan, Horace H. Rackham School of Graduate Studies | en_US |
dc.contributor.committeemember | Shewach, Donna S. | en_US |
dc.contributor.committeemember | Ljungman, Mats E D | en_US |
dc.contributor.committeemember | Rae, James M. | en_US |
dc.contributor.committeemember | Carey, Thomas E. | en_US |
dc.contributor.committeemember | Maybaum, Jonathan | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/98033/1/mmi_1.pdf | |
dc.owningcollname | Dissertations and Theses (Ph.D. and Master's) |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.